Suppression of Hb Bart's to improve tissue oxygenation and fetal development in homozygous alpha‐thalassemia

Intra‐uterine reduction of Hb Bart's only reached with exchange transfusions.

Saved in:
Bibliographic Details
Published in:American journal of hematology 2024-08, Vol.99 (8), p.1613-1615
Main Authors: Lugthart, G., Verweij, E. J. T., Harteveld, C. L., Tan, R. N. G. B., Knapen, M. F. C. M., Slaghekke, F., Haak, M. C., Mohseny, A. B., Smiers, F. J.
Format: Article
Language:English
Subjects:
Adult
alpha-Thalassemia - genetics
alpha-Thalassemia - therapy
Exchange Transfusion, Whole Blood
Female
Fetal Development
Fetuses
Hemoglobins, Abnormal - genetics
Homozygote
Humans
Infant, Newborn
Oxygen - metabolism
Pregnancy
Thalassemia
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites cdi_FETCH-LOGICAL-c3134-f588a03e3fe075001879d67b3cac936cddf54f6eac0ede2bd3da17a77e2c7f513
container_end_page 1615
container_issue 8
container_start_page 1613
container_title American journal of hematology
container_volume 99
creator Lugthart, G.
Verweij, E. J. T.
Harteveld, C. L.
Tan, R. N. G. B.
Knapen, M. F. C. M.
Slaghekke, F.
Haak, M. C.
Mohseny, A. B.
Smiers, F. J.
description Intra‐uterine reduction of Hb Bart's only reached with exchange transfusions.
doi_str_mv 10.1002/ajh.27344
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_3046518323</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3076829318</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3134-f588a03e3fe075001879d67b3cac936cddf54f6eac0ede2bd3da17a77e2c7f513</originalsourceid><addsrcrecordid>eNp10TFOwzAYBWALgaAUBi6ALDEAQ6kdJ3EyQgUUhMQAzNHf-DdNlcQhToAwcQTOyElwSWFAYrKHT0_PfoTscXbCGfPGsJifeFL4_hoZcBaHoygMvHUyYCLk7s7iLbJt7YIxzv2IbZIt4UAguTcg5V1bVTVam5mSGk2nM3oGdXNoaWNoVlS1eUbaZNa2SM1r94glNEsKpaIaG8ipwmfMTVVg2dCspHNTmLfu0bSWQl7N4fP9o5lDDtZikcEO2dCQW9xdnUPycHF-P5mObm4vryanN6NUcOGPdBBFwAQKjUwGrnckYxXKmUghjUWYKqUDX4cIKUOF3kwJBVyClOilUgdcDMlRn-se8NSibZIisynmOZToqiWC-WHAI-EJRw_-0IVp69K1c0qGkRcLB4fkuFdpbaytUSdVnRVQdwlnyXKExI2QfI_g7P4qsZ0VqH7lz687MO7BS5Zj939Scno97SO_ALbRkzw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3076829318</pqid></control><display><type>article</type><title>Suppression of Hb Bart's to improve tissue oxygenation and fetal development in homozygous alpha‐thalassemia</title><source>Wiley</source><creator>Lugthart, G. ; Verweij, E. J. T. ; Harteveld, C. L. ; Tan, R. N. G. B. ; Knapen, M. F. C. M. ; Slaghekke, F. ; Haak, M. C. ; Mohseny, A. B. ; Smiers, F. J.</creator><creatorcontrib>Lugthart, G. ; Verweij, E. J. T. ; Harteveld, C. L. ; Tan, R. N. G. B. ; Knapen, M. F. C. M. ; Slaghekke, F. ; Haak, M. C. ; Mohseny, A. B. ; Smiers, F. J.</creatorcontrib><description>Intra‐uterine reduction of Hb Bart's only reached with exchange transfusions.</description><identifier>ISSN: 0361-8609</identifier><identifier>ISSN: 1096-8652</identifier><identifier>EISSN: 1096-8652</identifier><identifier>DOI: 10.1002/ajh.27344</identifier><identifier>PMID: 38655712</identifier><language>eng</language><publisher>Hoboken, USA: John Wiley &amp; Sons, Inc</publisher><subject>Adult ; alpha-Thalassemia - genetics ; alpha-Thalassemia - therapy ; Exchange Transfusion, Whole Blood ; Female ; Fetal Development ; Fetuses ; Hemoglobins, Abnormal - genetics ; Homozygote ; Humans ; Infant, Newborn ; Oxygen - metabolism ; Pregnancy ; Thalassemia</subject><ispartof>American journal of hematology, 2024-08, Vol.99 (8), p.1613-1615</ispartof><rights>2024 Wiley Periodicals LLC.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c3134-f588a03e3fe075001879d67b3cac936cddf54f6eac0ede2bd3da17a77e2c7f513</cites><orcidid>0000-0002-3697-9316</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27923,27924</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38655712$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Lugthart, G.</creatorcontrib><creatorcontrib>Verweij, E. J. T.</creatorcontrib><creatorcontrib>Harteveld, C. L.</creatorcontrib><creatorcontrib>Tan, R. N. G. B.</creatorcontrib><creatorcontrib>Knapen, M. F. C. M.</creatorcontrib><creatorcontrib>Slaghekke, F.</creatorcontrib><creatorcontrib>Haak, M. C.</creatorcontrib><creatorcontrib>Mohseny, A. B.</creatorcontrib><creatorcontrib>Smiers, F. J.</creatorcontrib><title>Suppression of Hb Bart's to improve tissue oxygenation and fetal development in homozygous alpha‐thalassemia</title><title>American journal of hematology</title><addtitle>Am J Hematol</addtitle><description>Intra‐uterine reduction of Hb Bart's only reached with exchange transfusions.</description><subject>Adult</subject><subject>alpha-Thalassemia - genetics</subject><subject>alpha-Thalassemia - therapy</subject><subject>Exchange Transfusion, Whole Blood</subject><subject>Female</subject><subject>Fetal Development</subject><subject>Fetuses</subject><subject>Hemoglobins, Abnormal - genetics</subject><subject>Homozygote</subject><subject>Humans</subject><subject>Infant, Newborn</subject><subject>Oxygen - metabolism</subject><subject>Pregnancy</subject><subject>Thalassemia</subject><issn>0361-8609</issn><issn>1096-8652</issn><issn>1096-8652</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><recordid>eNp10TFOwzAYBWALgaAUBi6ALDEAQ6kdJ3EyQgUUhMQAzNHf-DdNlcQhToAwcQTOyElwSWFAYrKHT0_PfoTscXbCGfPGsJifeFL4_hoZcBaHoygMvHUyYCLk7s7iLbJt7YIxzv2IbZIt4UAguTcg5V1bVTVam5mSGk2nM3oGdXNoaWNoVlS1eUbaZNa2SM1r94glNEsKpaIaG8ipwmfMTVVg2dCspHNTmLfu0bSWQl7N4fP9o5lDDtZikcEO2dCQW9xdnUPycHF-P5mObm4vryanN6NUcOGPdBBFwAQKjUwGrnckYxXKmUghjUWYKqUDX4cIKUOF3kwJBVyClOilUgdcDMlRn-se8NSibZIisynmOZToqiWC-WHAI-EJRw_-0IVp69K1c0qGkRcLB4fkuFdpbaytUSdVnRVQdwlnyXKExI2QfI_g7P4qsZ0VqH7lz687MO7BS5Zj939Scno97SO_ALbRkzw</recordid><startdate>202408</startdate><enddate>202408</enddate><creator>Lugthart, G.</creator><creator>Verweij, E. J. T.</creator><creator>Harteveld, C. L.</creator><creator>Tan, R. N. G. B.</creator><creator>Knapen, M. F. C. M.</creator><creator>Slaghekke, F.</creator><creator>Haak, M. C.</creator><creator>Mohseny, A. B.</creator><creator>Smiers, F. J.</creator><general>John Wiley &amp; Sons, Inc</general><general>Wiley Subscription Services, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>K9.</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-3697-9316</orcidid></search><sort><creationdate>202408</creationdate><title>Suppression of Hb Bart's to improve tissue oxygenation and fetal development in homozygous alpha‐thalassemia</title><author>Lugthart, G. ; Verweij, E. J. T. ; Harteveld, C. L. ; Tan, R. N. G. B. ; Knapen, M. F. C. M. ; Slaghekke, F. ; Haak, M. C. ; Mohseny, A. B. ; Smiers, F. J.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3134-f588a03e3fe075001879d67b3cac936cddf54f6eac0ede2bd3da17a77e2c7f513</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Adult</topic><topic>alpha-Thalassemia - genetics</topic><topic>alpha-Thalassemia - therapy</topic><topic>Exchange Transfusion, Whole Blood</topic><topic>Female</topic><topic>Fetal Development</topic><topic>Fetuses</topic><topic>Hemoglobins, Abnormal - genetics</topic><topic>Homozygote</topic><topic>Humans</topic><topic>Infant, Newborn</topic><topic>Oxygen - metabolism</topic><topic>Pregnancy</topic><topic>Thalassemia</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lugthart, G.</creatorcontrib><creatorcontrib>Verweij, E. J. T.</creatorcontrib><creatorcontrib>Harteveld, C. L.</creatorcontrib><creatorcontrib>Tan, R. N. G. B.</creatorcontrib><creatorcontrib>Knapen, M. F. C. M.</creatorcontrib><creatorcontrib>Slaghekke, F.</creatorcontrib><creatorcontrib>Haak, M. C.</creatorcontrib><creatorcontrib>Mohseny, A. B.</creatorcontrib><creatorcontrib>Smiers, F. J.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><jtitle>American journal of hematology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lugthart, G.</au><au>Verweij, E. J. T.</au><au>Harteveld, C. L.</au><au>Tan, R. N. G. B.</au><au>Knapen, M. F. C. M.</au><au>Slaghekke, F.</au><au>Haak, M. C.</au><au>Mohseny, A. B.</au><au>Smiers, F. J.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Suppression of Hb Bart's to improve tissue oxygenation and fetal development in homozygous alpha‐thalassemia</atitle><jtitle>American journal of hematology</jtitle><addtitle>Am J Hematol</addtitle><date>2024-08</date><risdate>2024</risdate><volume>99</volume><issue>8</issue><spage>1613</spage><epage>1615</epage><pages>1613-1615</pages><issn>0361-8609</issn><issn>1096-8652</issn><eissn>1096-8652</eissn><abstract>Intra‐uterine reduction of Hb Bart's only reached with exchange transfusions.</abstract><cop>Hoboken, USA</cop><pub>John Wiley &amp; Sons, Inc</pub><pmid>38655712</pmid><doi>10.1002/ajh.27344</doi><tpages>3</tpages><orcidid>https://orcid.org/0000-0002-3697-9316</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0361-8609
ispartof American journal of hematology, 2024-08, Vol.99 (8), p.1613-1615
issn 0361-8609
1096-8652
1096-8652
language eng
recordid cdi_proquest_miscellaneous_3046518323
source Wiley
subjects Adult
alpha-Thalassemia - genetics
alpha-Thalassemia - therapy
Exchange Transfusion, Whole Blood
Female
Fetal Development
Fetuses
Hemoglobins, Abnormal - genetics
Homozygote
Humans
Infant, Newborn
Oxygen - metabolism
Pregnancy
Thalassemia
title Suppression of Hb Bart's to improve tissue oxygenation and fetal development in homozygous alpha‐thalassemia
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-12T20%3A50%3A39IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Suppression%20of%20Hb%20Bart's%20to%20improve%20tissue%20oxygenation%20and%20fetal%20development%20in%20homozygous%20alpha%E2%80%90thalassemia&rft.jtitle=American%20journal%20of%20hematology&rft.au=Lugthart,%20G.&rft.date=2024-08&rft.volume=99&rft.issue=8&rft.spage=1613&rft.epage=1615&rft.pages=1613-1615&rft.issn=0361-8609&rft.eissn=1096-8652&rft_id=info:doi/10.1002/ajh.27344&rft_dat=%3Cproquest_cross%3E3076829318%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c3134-f588a03e3fe075001879d67b3cac936cddf54f6eac0ede2bd3da17a77e2c7f513%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=3076829318&rft_id=info:pmid/38655712&rfr_iscdi=true